Clinical features of patients bearing central nervous system hemangioblastoma in von Hippel-Lindau disease

Acta Neurochirurgica

Volumn 155, Issue 1, 2013, Pages 1-7

  Kanno, Hiroshi ^a   Kuratsu, Jun Ichi ^b   Nishikawa, Ryo ^c   Mishima, Kazuhiko ^c   Natsume, Atushi ^d   Wakabayashi, Toshihiko ^d   Houkin, Kiyohiro ^e   Terasaka, Shunsuke ^e   Shuin, Taro ^f  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Central nervous system hemangioblastoma; Clinical features; Quality of life; Von Hippel Lindau disease

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN STEM TUMOR; CANCER SURGERY; CEREBELLUM TUMOR; CHILD; CLINICAL FEATURE; FEMALE; FOLLOW UP; HEMANGIOBLASTOMA; HUMAN; HYPOPHYSIS TUMOR; MAJOR CLINICAL STUDY; MALE; MULTIPLE CANCER; ONSET AGE; OPERATION DURATION; PRIORITY JOURNAL; QUALITY OF LIFE; SCHOOL CHILD; SPINAL CORD TUMOR; TUMOR LOCALIZATION; VON HIPPEL LINDAU DISEASE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; COHORT STUDIES; FEMALE; HEALTH STATUS INDICATORS; HEMANGIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; VON HIPPEL-LINDAU DISEASE; YOUNG ADULT;

EID: 84872032079     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-012-1514-y     Document Type: Article

References (17)

1. Ammerman JM, Lonser RR, Dambrosia J, Butman JA, Oldfield EH (2006) Long-term natural history of hemangioblastomas in patients with von Hippel-Lindau disease: implications for treatment. J Neurosurg 105:248-255
2. Colombo N, Kucharczyk W, Brant-Zawadzki M, Norman D, Scotti G, Newton TH (1986) Magnetic resonance imaging of spinal cord hemangioblastoma. Acta Radiol Suppl 369:734-737
3. Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D (2001) Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery 48:55-63
4. Filling-Katz MR, Choyke PL, Oldfield E, Charnas L, Patronas N, Glenn G, Gorin M, Morgan J, Linehan W, Seizinger B, Zbar B (1991) Central nervous system involvement in Von Hippel-Lindau disease. Neurology 41:41-46
5. Kanno H, Kondo K, Ito S, Yamamoto I, Fujii S, Trigoe S, Sakai N, Hosaka M, Shuin T, Yao M (1994) Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54:4845-4847
6. Kanno H, Yamamoto I, Nishikawa R, Matsutani M, Wakabayashi T, Yoshida J, Shitara N, Yamasaki I, Shuin T, Clinical VHL Research Group in Japan (2009) Spinal cord hemangioblastomas in von Hippel-Lindau disease. Spinal Cord 47
7. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei MH, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan DR, Dean A, Glavac D, Richards FM, Crossey PA, Ferguson-Smith MA, Le Paslier D, Chumakov I, Cohen D, Chinault CA, Maher ER, Linehan WM, Zbar B (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260:1317-1320
8. Lonser RR, Butman JA, Kiringoda R, Song D, Oldfield EH (2009) Pituitary stalk hemangioblastomas in von Hippel-Lindau disease. J Neurosurg 110(2):350-353
9. Lonser R, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, Oldfield EH (2003) Von Hippel-Lindau disease. Lancet 361:2059-2067
10. Neumann HP, Eggert HR, Scheremet R, Schumacher M, Mohadjer M, Wakhloo A, Volk B, Hettmannsperger U, Riegler P, Schollmeyer P, Wiestler O (1992) Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 55:898-901
11. Neumann HP, Lips CJ, Hsia YE, Zbar B (1995) Von Hippel-Lindau syndrome. Brain Pathol 5:181-193
12. Maher ER, Kaelin WG Jr (1997) von Hippel-Lindau disease. Medicine (Baltimore) 76:381-391
13. Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-Smith MA (1990) Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77:1151-1163
14. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655
15. Park DM, Zhuang Z, Chen L, Szerlip N, Maric I, Li J, Sohn T, Kim SH, Lubensky IA, Vortmeyer AO, Rodgers GP, Oldfield EH, Lonser RR (2007) von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells. PLoS Med 4:333-341
16. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman M, Yao M (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinoma. Cancer Res 54:2852-2855
17. Wanebo JE, Lonser RR, Glenn GM, Oldfield EH (2003) The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 98:82-94